Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company focused on oncology, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. David Hung, M.D., who serves as the company's Founder, President, and Chief Executive Officer, will deliver a presentation on Monday, January 13, 2025, at 9:00 a.m. PT in San Francisco, California.
The presentation will be accessible through a live webcast on the company's investor relations website. For those unable to attend live, an archived recording will remain available for 30 days after the event.
Nuvation Bio (NYSE: NUVB), una società biopharmaceutica globale focalizzata sull'oncologia, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. David Hung, M.D., fondatore, presidente e amministratore delegato dell'azienda, presenterà lunedì 13 gennaio 2025, alle 9:00 PT a San Francisco, California.
La presentazione sarà accessibile tramite un webcast dal vivo sul sito delle relazioni con gli investitori della società. Per coloro che non possono partecipare dal vivo, sarà disponibile una registrazione archiviata per 30 giorni dopo l'evento.
Nuvation Bio (NYSE: NUVB), una empresa biofarmacéutica global centrada en oncología, ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. David Hung, M.D., fundador, presidente y director ejecutivo de la compañía, ofrecerá una presentación el lunes 13 de enero de 2025, a las 9:00 a.m. PT en San Francisco, California.
La presentación será accesible a través de una transmisión en vivo en el sitio web de relaciones con los inversores de la empresa. Para aquellos que no puedan asistir en vivo, se mantendrá disponible una grabación archivada durante 30 días después del evento.
Nuvation Bio (NYSE: NUVB), 종양학에 중점을 둔 글로벌 생명공학 회사, 제43회 JP모건 헬스케어 컨퍼런스에 참석할 것이라고 발표했습니다. David Hung, M.D., 회사의 설립자이자 사장 및 CEO는 2025년 1월 13일 월요일, 오전 9시 PT에 샌프란시스코, 캘리포니아에서 발표를 진행할 예정입니다.
발표는 회사의 투자자 관계 웹사이트를 통해 생중계로 시청할 수 있습니다. 생중계를 시청할 수 없는 분들을 위해, 이벤트 종료 후 30일 동안 아카이브된 녹화본이 제공될 것입니다.
Nuvation Bio (NYSE: NUVB), une entreprise biopharmaceutique mondiale axée sur l'oncologie, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. David Hung, M.D., qui est le fondateur, président et directeur général de l'entreprise, fera une présentation le lundi 13 janvier 2025, à 9h00 PT à San Francisco, Californie.
La présentation sera accessible via un webcast en direct sur le site web des relations investisseurs de l'entreprise. Pour ceux qui ne peuvent pas assister en direct, un enregistrement archivé restera disponible pendant 30 jours après l'événement.
Nuvation Bio (NYSE: NUVB), ein globales biopharmazeutisches Unternehmen mit Fokus auf Onkologie, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. David Hung, M.D., der als Gründer, Präsident und CEO des Unternehmens tätig ist, wird am Montag, den 13. Januar 2025, um 9:00 Uhr PT in San Francisco, Kalifornien, eine Präsentation halten.
Die Präsentation wird über einen Live-Webcast auf der Investor-Relations-Website des Unternehmens zugänglich sein. Für diejenigen, die nicht live teilnehmen können, bleibt eine archivierte Aufzeichnung 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
A live webcast of the presentation will be available on the Nuvation Bio website at https://investors.nuvationbio.com/investors/. An archived recording will be available for 30 days following the event.
About Nuvation Bio
Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates. Nuvation Bio’s programs include taletrectinib (ROS1), safusidenib (mIDH1), NUV-1511 (DDC), and NUV-868 (BET). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106569923/en/
Nuvation Bio Investor Contact:
ir@nuvationbio.com
Nuvation Bio Media Contact:
media@nuvationbio.com
Source: Nuvation Bio Inc.
FAQ
When is Nuvation Bio (NUVB) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Nuvation Bio's (NUVB) J.P. Morgan Healthcare Conference presentation?
How long will Nuvation Bio's (NUVB) 2025 J.P. Morgan presentation recording be available?
Who will represent Nuvation Bio (NUVB) at the 2025 J.P. Morgan Healthcare Conference?
